EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam

Hai Trong Nguyen, Darryl Falzarano iD, Volker Gerdts, Qiang Liu iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.00959-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Hai Trong Nguyen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Hauptthemen laut MEDLINE: SARS-CoV-2, Vaccines, Virus-Like Particle, Baculoviridae, Antibodies, Viral. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCD NIH HHS, Canadian Government | Canadian Institutes of Health Research (CIHR), Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve to give rise to variants of concern that can escape vaccine-induced immunity. As such, more effective vaccines are urgently needed. In this study, we evaluated virus-like particle (VLP) as a vaccine platform for SARS-CoV-2. The spike, envelope, and membrane proteins of the SARS-CoV-2 Wuhan strain were expressed by a single recombinant baculovirus BacMam and assembled into VLPs in cell culture. The morphology and size of the SARS-CoV-2 VLP as shown by transmission electron microscopy were similar to the authentic SARS-CoV-2 virus particle. In a mouse trial, two intramuscular immunizations of the VLP BacMam with no adjuvant elicited spike-specific binding antibodies in both sera and bronchoalveolar lavage fluids. Importantly, BacMam VLP-vaccinated mouse sera showed neutralization activity against SARS-CoV-2 spike pseudotyped lentivirus. Our results indicated that the SARS-CoV-2 VLP BacMam stimulated spike-specific immune responses with neutralization activity. IMPORTANCE Although existing vaccines have significantly mitigated the impact of the COVID-19 pandemic, none of the vaccines can induce sterilizing immunity. The spike protein is the main component of all approved vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) due primarily to its ability to induce neutralizing antibodies. The conformation of the spike protein in the vaccine formulation should be critical for the efficacy of a vaccine. By way of closely resembling the authentic virions, virus-like particles (VLPs) should render the spike protein in its natural conformation. To this end, we utilized the baculovirus vector, BacMam, to express virus-like particles consisting of the spike, membrane, and envelope proteins of SARS-CoV-2. We demonstrated the immunogenicity of our VLP vaccine with neutralizing activity. Our data warrant further evaluation of the virus-like particles as a vaccine candidate in protecting against virus challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Vaccines, Virus-Like ParticleBaculoviridaeAntibodies, ViralSpike Glycoprotein, CoronavirusCOVID-19 VaccinesCOVID-19Antibodies, NeutralizingMice, Inbred BALB CAnimalsMiceHumansFemaleImmunogenicity, VaccineCoronavirus Envelope ProteinsCoronavirus M Proteins

Stichwörter der Autor:innen

SARS-CoV-2baculovirus BacMamimmune responseneutralizing antibodypseudotyped lentivirusvaccinevirus-like particle

Substanzen

Vaccines, Virus-Like ParticleAntibodies, ViralSpike Glycoprotein, CoronavirusCOVID-19 VaccinesAntibodies, Neutralizingspike protein, SARS-CoV-2Coronavirus Envelope Proteinsmembrane protein, SARS-CoV-2Coronavirus M Proteins

Autor:innen und Institutionen

  • Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Vaccinology and Immunotherapeutics, School of Public Health, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

ORCID-Profile: Darryl Falzarano, Qiang Liu

Förderung

  • NIDCD NIH HHS
  • Canadian Government | Canadian Institutes of Health Research (CIHR)
  • Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC)
  • Saskatchewan Agriculture Development Fund

Zitieren

APA

Nguyen, H. T., Falzarano, D., Gerdts, V., & Liu, Q. (2024). Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00959-24

Vancouver

Nguyen HT, Falzarano D, Gerdts V, Liu Q. Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00959-24

BibTeX
@article{Nguyen2024,
  author = {Nguyen, Hai Trong and Falzarano, Darryl and Gerdts, Volker and Liu, Qiang},
  title = {Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.00959-24}
}
Kostenlos starten →